QP3-RT 20mg
Investigational triple receptor agonist for metabolic research.
QP3-RT is an investigational 39-amino-acid peptide designed to activate three receptors at once: two incretin receptors and the glucagon receptor. The 20 mg vial sits in the middle of the catalog's three sizes, a practical choice for medium-length assay series.
The scientific interest in a triple agonist comes from combining dual incretin-receptor effects with glucagon-receptor signaling, which in liver and adipose models is associated with energy expenditure and hepatic lipid metabolism. Preclinical and receptor-level studies examine how the balance among the three activities shapes glucose handling, lipid metabolism and liver fat content, and how a triple profile compares with single and dual agonists in the same system. Like other long-acting incretin analogs, QP3-RT carries a fatty-acid modification that supports albumin binding.
This vial has a third-party certificate of analysis (batch COA #10446, 99.84% by RP-HPLC, issued by Bioviridian Inc.). For laboratory research use only.
Research areas: Triple receptor agonism, Glucagon receptor signaling, Hepatic lipid metabolism, Comparative incretin pharmacology.
Category: Metabolic. Price: $75.95 USD. 99.84% HPLC purity (third-party lab tested, batch COA #10446: https://orderqualitypeptides.com/coa/COA10446.pdf).
All products are sold strictly for in-vitro laboratory research. Not for human or veterinary use. Not drugs or supplements.